Despite Zoetis' underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish ...

These two stocks come from completely different industries, but each could boost a long-term investor's returns.

Zoetis Inc. (NYSE:ZTS) is one of the best defensive stocks to invest in according to analysts. On July 10, Bank of America ...

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected to advance at a ...

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected ...

In addition to TD Cowen, Zoetis also received a Buy from William Blair’s Brandon Vazquez in a report issued today. However, on July 31, Stifel Nicolaus maintained a Hold rating on Zoetis (NYSE: ZTS).

Ex-Fox News Host Confirmed by Senate in 50-45 Vote Ozzy Osbourne’s cause of death revealed after rock legend’s funeral Army ...

Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a second-quarter 2025 adjusted earnings per share of $1.76, up ...

Zoetis Inc. Q2 2025 earnings highlight 8% organic revenue growth, raised guidance, and strong performance from Simparica and Key Dermatology franchises.

Zoetis (ZTS) stock surges premarket as the company posts strong Q2 2025 results and raises full-year outlook. Read more here.

Meanwhile, the company has an impeccable dividend program. The company has increased its payouts by 502% over the past decade ...